The microvacular thrombi of colonic tissue in ulcerative colitis

被引:10
作者
He, Guobin [1 ]
Ouyang, Qin
Chen, Daiyun
Li, Fengyuan
Zhou, Jingguo
机构
[1] Affiliated Hosp N Sichuan Med Coll, Dept Gastroenterol, Sichuan 637000, Peoples R China
[2] Affiliated Hosp N Sichuan Med Coll, Dept Hematol, Sichuan 637000, Peoples R China
[3] Sichuan Univ, Huaxi Hosp, Dept Gastroenterol, Chengdu 610041, Peoples R China
[4] Sichuan Univ, Huaxi Hosp, Dept Pathol, Chengdu 610041, Peoples R China
关键词
ulcerative colitis; microvacular thrombi; thrombosis;
D O I
10.1007/s10620-006-9158-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mucosal microvacular thrombi in rectal biopsies were observed in some ulcerative colitis (UC). Heparin may be effective in steroid resistant UC in some studies, however, the new results of meta-analysis demonstrated a non-significant effect of heparin in controlled clinical trials, differing markedly from observational studies. The objective of this study was to identify colonic microvascular thrombi in larger cases with UC, and analyse its possible risk factors: age, gender, histologic score, extent of lesions and operation or biopsy specimens, and assess the significance of microvascular thrombosis in patients with UC. The microvascular thrombi were identified by immunohistochemical staining with anti-CD61 monoclonal antibody and Martius scarlet blue (MSB) staining in 40 colonic tissue samples of UC (31 biopsy specimens and nine operated cases) and 12 cases of normal colon tissue from operated colonic carcinoma. Logistic regression analysis was used to assess the relationship of age, gender, degree of histology, origin of the specimens, extent of lesions and microvascular thrombi examined. Microvascular thrombi were positive in 14 of 40 UC cases, and none in the controls. The presence of microvascular thrombi was related to operation specimens with odds ratio 11.667, P=0.0179, it might be also related to histologic score (OR=1.350) and extent of lesions (OR=1.619). These results suggest that microvascular thrombosis may be one of the important pathogenesis in some UC, and that the effect of anticoagulant treatment still needs to be assessed.
引用
收藏
页码:2236 / 2240
页数:5
相关论文
共 32 条
[1]   Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease [J].
Ang, YS ;
Mahmud, N ;
White, B ;
Byrne, M ;
Kelly, A ;
Lawler, M ;
McDonald, GSA ;
Smith, OP ;
Keeling, PWN .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (08) :1015-1022
[2]   Inhibitory effects of low molecular weight heparin on mediator release by mast cells: preferential inhibition of cytokine production and mast cell dependent cutaneous inflammation [J].
Baram, D ;
Rashkovsky, M ;
Hershkoviz, R ;
Drucker, I ;
Reshef, T ;
Ben-Shitrit, S ;
Mekori, YA .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 110 (03) :485-491
[3]  
Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430
[4]  
BIANCONE L, 1994, ITAL J GASTROENTEROL, V26, P116
[5]   Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis [J].
Bloom, S ;
Kiilerich, S ;
Lassen, MR ;
Forbes, A ;
Leiper, K ;
Langholz, E ;
Irvine, EJ ;
O'Morain, C ;
Lowson, D ;
Orm, S .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (08) :871-878
[6]   Expression of syndecan-1 in inflammatory bowel disease and a possible mechanism of heparin therapy [J].
Day, R ;
Ilyas, M ;
Talbot, I ;
Forbes, A ;
Daszak, P .
DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (12) :2508-2515
[7]   MUCOSAL CAPILLARY THROMBI IN RECTAL BIOPSIES [J].
DHILLON, AP ;
ANTHONY, A ;
SIM, R ;
WAKEFIELD, AJ ;
SANKEY, EA ;
HUDSON, M ;
ALLISON, MC ;
POUNDER, RE .
HISTOPATHOLOGY, 1992, 21 (02) :127-133
[8]   Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis - An open trial [J].
Dotan, I ;
Hallak, A ;
Arber, N ;
Santo, M ;
Alexandrowitz, A ;
Knaani, Y ;
Hershkoviz, R ;
Brazowski, E .
DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (10) :2239-2244
[9]   Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats [J].
Dotan, I ;
Hershkoviz, R ;
Karmeli, F ;
Brazowski, E ;
Peled, Y ;
Rachmilewitz, D ;
Halpern, Z .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (10) :1687-1697
[10]   Treatment of corticosteroid-resistant ulcerative colitis with heparin - a report of 16 cases [J].
Evans, RC ;
Wong, VS ;
Morris, AI ;
Rhodes, JM .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (06) :1037-1040